Literature DB >> 15774237

PSA updated: still relevant in the new millennium?

Jay B Shah1, Adam C Reese, James M McKiernan, Mitchell C Benson.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15774237     DOI： 10.1016/j.eururo.2004.12.020

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  6 in total

1.  Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3-10 ng/ml.

Authors:  Ahmed A Elabbady; Mahrousa M Khedr
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Recent developments in prostate cancer biomarker research: therapeutic implications.

Authors:  Sujitra Detchokul; Albert G Frauman
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

Review 3.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

Review 4.  Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer.

Authors:  M H Wink; J J M C H de la Rosette; C A Grimbergen; H Wijkstra
Journal:  World J Urol       Date:  2007-06-27       Impact factor: 4.226

5.  Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.

Authors:  Hui-chan He; Xue-cheng Bi; Zhi-wei Zheng; Qi-shan Dai; Zhao-Dong Han; Yu-Xiang Liang; Yong-Kang Ye; Guo-hua Zeng; Gang Zhu; Wei-de Zhong
Journal:  Med Oncol       Date:  2008-11-12       Impact factor: 3.064

Review 6.  Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.

Authors:  Sergey Reva; Alexander Nosov; Roman Novikov; Sergey Petrov
Journal:  Int Sch Res Notices       Date:  2014-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.